Advertisement
UK markets close in 2 hours 35 minutes

  • FTSE 100

    8,129.70
    +50.84 (+0.63%)
     

  • FTSE 250

    19,827.06
    +225.08 (+1.15%)
     

  • AIM

    755.17
    +2.05 (+0.27%)
     

  • GBP/EUR

    1.1668
    +0.0012 (+0.10%)
     

  • GBP/USD

    1.2505
    -0.0006 (-0.05%)
     

  • Bitcoin GBP

    51,291.29
    +597.05 (+1.18%)
     

  • CMC Crypto 200

    1,390.37
    -6.17 (-0.44%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    84.27
    +0.70 (+0.84%)
     

  • GOLD FUTURES

    2,359.60
    +17.10 (+0.73%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,090.91
    +173.63 (+0.97%)
     

  • CAC 40

    8,064.70
    +48.05 (+0.60%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

STOCKS NEWS EUROPE-Nobel Biocare drops on cautious outlook

Reuters - UK Focus

Shares in Nobel Biocare (Other OTC: NBHGF - news) fall more than 6 percent after the Swiss dental implant maker posts fourth-quarter results that fall short of expectations and disappoint investors with a cautious guidance for full-year profitability.

"Its outlook for 2014 sales growth is as expected, but should be met with disappointment with regard to its guidance for margin development," writes ZKB analyst Sybille Bischofberger, who rates the stock as 'underweight.'

"The dental implant market is only recovering slowly and remains difficult," she says.

The company expects to improve its earnings before interest and tax (EBIT) margin by about 1 percentage point, below consensus forecasts.

Nobel Biocare is the worst performer on the Swiss mid cap index.

Reuters Messaging rm://caroline.copleyreuters.com@reuters.net